Reiteration - Spark Newswire

1 minute read

Qualtrics Could Bag A Higher Takeover Premium, Analyst Says Post Offer From Silver Lake & Canada Pension Plan

Today, 9:31 AM

Piper Sandler analyst Brent Bracelin maintains Qualtrics International Inc (NASDAQ:XM) with an Overweight, raising the price target from $16 to $18.15. On…

SAP

1 minute read

Needham Reiterates Buy on Riot Platforms, Maintains $9 Price Target

By Benzinga Newsdesk

Today, 9:31 AM

Needham analyst John Todaro reiterates Riot Platforms (NASDAQ:RIOT) with a Buy and maintains $9 price target.

RIOT

1 minute read

Needham Reiterates Buy on Ciena, Maintains $70 Price Target

By Benzinga Newsdesk

Today, 9:31 AM

Needham analyst Alex Henderson reiterates Ciena (NYSE:CIEN) with a Buy and maintains $70 price target.

CIEN

1 minute read

Needham Reiterates Buy on SEMrush Hldgs, Maintains $20 Price Target

By Benzinga Newsdesk

Today, 9:31 AM

Needham analyst Scott Berg reiterates SEMrush Hldgs (NYSE:SEMR) with a Buy and maintains $20 price target.

SEMR

1 minute read

Needham Reiterates Buy on RxSight, Maintains $22 Price Target

By Benzinga Newsdesk

Today, 9:31 AM

Needham analyst David Saxon reiterates RxSight (NASDAQ:RXST) with a Buy and maintains $22 price target.

RXST

1 minute read

Telsey Advisory Group Reiterates Outperform on Lulus Fashion Lounge, Maintains $9 Price Target

By Benzinga Newsdesk

Today, 9:31 AM

Telsey Advisory Group analyst Dana Telsey reiterates Lulus Fashion Lounge (NASDAQ:LVLU) with a Outperform and maintains $9 price target.

LVLU

1 minute read

Needham Reiterates Buy on Stoke Therapeutics, Maintains $25 Price Target

By Benzinga Newsdesk

Today, 9:31 AM

Needham analyst Joseph Stringer reiterates Stoke Therapeutics (NASDAQ:STOK) with a Buy and maintains $25 price target.

STOK

1 minute read

Piper Sandler Reiterates Neutral on Olo, Maintains $9 Price Target

By Benzinga Newsdesk

Today, 9:31 AM

Piper Sandler analyst Clarke Jeffries reiterates Olo (NYSE:OLO) with a Neutral and maintains $9 price target.

OLO

1 minute read

HC Wainwright & Co. Reiterates Buy on Armata Pharmaceuticals, Maintains $7 Price Target

By Benzinga Newsdesk

Today, 9:31 AM

HC Wainwright & Co. analyst Joseph Pantginis reiterates Armata Pharmaceuticals (AMEX:ARMP) with a Buy and maintains $7 price target.

ARMP

2 minute read

Tesla Loses ‘Top Pick’ Status: Analyst Backs This Luxury Carmaker As Best Positioned To Weather Challenges

By Shanthi Rexaline

Today, 9:31 AM

Tesla Inc.

RACE